In the case of Dexcom, the innovator in continuous glucose monitoring (GCM) devices flushed out weak holders during a test of institutional support near its 10-week moving average (the red line on IBD weekly charts).A Relative Strength Rating upgrade for Aaron's shows improving technical...  Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5!